Instituto Universitario de Investigación en Neuroquímica
Centro/Instituto
![Foto de Alma](/img/nophoto.png)
Alma
Viso Beronda
Publicaciones en las que colabora con Alma Viso Beronda (28)
2017
-
Development of a Nucleotide Exchange Inhibitor That Impairs Ras Oncogenic Signaling
Chemistry - A European Journal, Vol. 23, Núm. 7, pp. 1676-1685
2011
-
Development of non-peptide ligands of growth factor receptor-bound protein 2-src homology 2 domain using molecular modeling and NMR spectroscopy
Journal of Medicinal Chemistry, Vol. 54, Núm. 4, pp. 1096-1100
2010
-
Development of fluorescent ligands for the human 5-HT1A receptor
ACS Medicinal Chemistry Letters, Vol. 1, Núm. 6, pp. 249-253
-
Development of molecular probes for the human 5-HT6 receptor
Journal of Medicinal Chemistry, Vol. 53, Núm. 19, pp. 7095-7106
2008
-
The medicinal chemistry of agents targeting monoacylglycerol lipase
Current Topics in Medicinal Chemistry, Vol. 8, Núm. 3, pp. 231-246
2005
-
Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis
FASEB Journal, Vol. 19, Núm. 10, pp. 1338-1340
-
Involvement of cannabinoids in cellular proliferation
Mini-Reviews in Medicinal Chemistry
-
Synthesis and structure-activity relationships of a new model of arylpiperazines. 8. Computational simulation of ligand-receptor interaction of 5-HT1AR agonists with selectivity over α1- adrenoceptors
Journal of Medicinal Chemistry, Vol. 48, Núm. 7, pp. 2548-2558
2004
-
Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: Synthesis of new transporter inhibitors as tools for this study
British Journal of Pharmacology, Vol. 141, Núm. 3, pp. 457-467
-
Comparison of anandamide transport in FAAH wild-type and knockout neurons: Evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake
Biochemistry, Vol. 43, Núm. 25, pp. 8184-8190
-
Synthesis and structure-activity relationships of a new model of arylpiperazines. Part 7: Study of the influence of lipophilic factors at the terminal amide fragment on 5-HT1A affinity/selectivity
Bioorganic and Medicinal Chemistry, Vol. 12, Núm. 6, pp. 1551-1557
2003
-
Design and synthesis of S-(-)-2-[[4-(napht-1-yl)piperazin-1-yl]methyl]-1,4-dioxoperhydropyrrolo[1,2- a]pyrazine (CSP-2503) using computational simulation. A 5-HT1A receptor agonist
Bioorganic and Medicinal Chemistry Letters, Vol. 13, Núm. 8, pp. 1429-1432
-
Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors
European Journal of Medicinal Chemistry
-
Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: Comparison with effects on fatty acid amidohydrolase
Journal of Medicinal Chemistry, Vol. 46, Núm. 8, pp. 1512-1522
-
Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 18, Núm. 3, pp. 225-231
-
VR1 receptor modulators as potential drugs for neuropathic pain.
Mini reviews in medicinal chemistry, Vol. 3, Núm. 7, pp. 729-748
2002
-
5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.
Current topics in medicinal chemistry, Vol. 2, Núm. 6, pp. 625-641
-
Arylpiperazine derivatives acting at 5-HT1A receptors
Current Medicinal Chemistry, Vol. 9, Núm. 4, pp. 443-469
-
Benzimidazole derivatives. 3. 3D-QSAR/CoMFA model and computational simulation for the recognition of 5-HT4 receptor antagonists
Journal of Medicinal Chemistry, Vol. 45, Núm. 22, pp. 4806-4815
-
Endocannabinoid transporter inhibitors
Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Núm. 2, pp. 129-141